In reply: Can GnRH analogues preserve gonadal function without preserving fertility?

Oncologist

Volumn 13, Issue 5, 2008, Pages 615-617

  Sönmezer, Murat ^a   Bang, Heejung ^b   Oktay, Kutluk ^c,d  

^a ANKARA UNIVERSITY   (Turkey)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d CENTER FOR HUMAN REPRODUCTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST;

AMENORRHEA; DRUG EFFECT; DRUG EFFICACY; ELECTRON MICROSCOPY; FERTILITY; HORMONE ACTION; HUMAN; LETTER; MENSTRUAL CYCLE; OVARY FOLLICLE CELL; OVARY FUNCTION; PATIENT CARE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SURVIVAL;

EID: 45749124477     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2008-0053     Document Type: Letter

References (14)

1. Reh A, Oktem O, Oktay K. Impact of breast cancer chemotherapy on ovarian reserve: A prospective observational analysis by menstrual history and ovarian reserve markers. Fertil Steril 2007 Dec 29; [Epub ahead of print].
2. Klein NA, Harper AJ, Houmard BS et al. Is the short follicular phase in older women secondary to advanced or accelerated dominant follicle development? J Clin Endocrinol Metab 2002;87:5746-5750.
3. Klein NA, Illingworth PJ, Groome NP et al. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: A study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 1996;81:2742-2745.
4. Familiari G, Caggiati A, Nottola SA et al. Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease. Hum Reprod 1993;8:2080-2087.
5. Oktay K, Sönmezer M, Oktem O et al. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. The Oncologist 2007;12:1055-1066.
6. Giuseppe L, Attilio G, Edoardo DN et al. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). Hematology 2007;12:141-147.
7. Ioannidis JP. Contradicted and initially stronger effects in highly cited clinical research. JAMA 2005;294:218-228.
8. Hoenig J, Heisey D. The abuse of power: The pervasive fallacy of power calculations for data analysis. Am Stat 2001;55:1-6.
9. Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283: 2008-2012.
10. Pocock SJ, Elbourne DR. Randomized trials or observational tribulations? N Engl J Med 2000;342:1907-1909.
11. Barton S. Which clinical studies provide the best evidence? The best RCT still trumps the best observational study. BMJ 2000;321:255-256.
12. Young SS, Bang H. The file-drawer problem, revisited. Science 2004;306: 1133-1134.
13. Fisher JC, Bang H, Kapiga SH. The association between HIV infection and alcohol use: A systematic review and meta-analysis of African studies. Sex Transm Dis 2007;34:856-863.
14. Bang H. Introduction to observational studies. In: Faries DE, Leon AC, Haro JM et al., eds. Analysis of Observational Health-Care Data Using SAS. Cary, NC: SAS Institute, Inc. In press (2009).